Literature DB >> 21851488

Infections in traumatic brain injury patients.

I S Kourbeti1, A F Vakis, J A Papadakis, D A Karabetsos, G Bertsias, M Filippou, A Ioannou, C Neophytou, M Anastasaki, G Samonis.   

Abstract

Traumatic brain injury (TBI) victims are considered to be at high risk for infection. The purpose of this cohort study was to delineate the rates, types and risk factors for infection in TBI patients. Retrospective surveillance of infections was conducted for all TBI patients, aged ≥18 years, cared for at the Department of Neurosurgery of the University Hospital of Heraklion, Greece, between 1999 and 2005. A total of 760 patients (75% men) with a median age of 41 years were included. Most (59%) were injured in a motor vehicle accident. One third of them underwent a surgical procedure. Two hundred and fourteen infections were observed. The majority were infections of the lower respiratory tract (47%), followed by surgical site infections (SSI) (17%). Multivariate analysis showed that SSI development was independently associated with the performance of ≥2 surgical procedures (OR 16.7), presence of concomitant infections, namely VAP (OR 5.7) and UTI (OR 8.8), insertion of lumbar (OR 34.5) and ventricular drains (OR 4.0), and cerebrospinal fluid (CSF) leak (OR 3.8). Development of meningitis was associated with prolonged hospitalization (OR 1.02), especially >7 days ICU stay (OR 25.5), and insertion of lumbar (OR 297) and ventricular drains (OR 9.1). There was a notable predominance of Acinetobacter spp. as a VAP pathogen; gram-positive organisms remained the most prevalent in SSI cases. Respiratory tract infections were the most common among TBI patients. Device-related communication of the CSF with the environment and prolonged hospitalization, especially in the ICU setting, were independent risk factors for SSIs and meningitis cases.
© 2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21851488     DOI: 10.1111/j.1469-0691.2011.03625.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  29 in total

Review 1.  Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation.

Authors:  Zhihan Wang; Qinqin Pu; Canhua Huang; Min Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Diagnostic Accuracy of Peripheral White Blood Cell Count, Fever and Acute Leukocutosis for Bacterial Meningitis in Patients with Severe Traumatic Brain Injury.

Authors:  Hosseinali Khalili; Golnaz YadollahiKhales; Mohammad Isaee
Journal:  Bull Emerg Trauma       Date:  2015-04

3.  The Impact of Capping Creatinine Clearance on Achieving Therapeutic Vancomycin Concentrations in Neurocritically Ill Patients with Traumatic Brain Injury.

Authors:  Nicholas R Nelson; Kathryn A Morbitzer; J Dedrick Jordan; Denise H Rhoney
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

Review 4.  Healthcare-Associated Infections in the Neurocritical Care Unit.

Authors:  Katharina M Busl
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-27       Impact factor: 5.081

5.  Stroke-associated infection independently predicts 3-month poor functional outcome and mortality.

Authors:  Satoshi Suda; Junya Aoki; Takashi Shimoyama; Kentaro Suzuki; Yuki Sakamoto; Takehiro Katano; Seiji Okubo; Chikako Nito; Yasuhiro Nishiyama; Masahiro Mishina; Kazumi Kimura
Journal:  J Neurol       Date:  2017-12-16       Impact factor: 4.849

6.  Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function.

Authors:  Sarah J Doran; Rebecca J Henry; Kari Ann Shirey; James P Barrett; Rodney M Ritzel; Wendy Lai; Jorge C Blanco; Alan I Faden; Stefanie N Vogel; David J Loane
Journal:  Crit Care Med       Date:  2020-05       Impact factor: 7.598

Review 7.  TBI Rehabilomics Research: Conceptualizing a humoral triad for designing effective rehabilitation interventions.

Authors:  A K Wagner; R G Kumar
Journal:  Neuropharmacology       Date:  2018-09-14       Impact factor: 5.250

8.  MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury.

Authors:  Saifudeen Ismael; Sanaz Nasoohi; Tauheed Ishrat
Journal:  J Neurotrauma       Date:  2018-04-02       Impact factor: 5.269

Review 9.  Microdialysis Monitoring in Clinical Traumatic Brain Injury and Its Role in Neuroprotective Drug Development.

Authors:  Eric Peter Thelin; Keri L H Carpenter; Peter J Hutchinson; Adel Helmy
Journal:  AAPS J       Date:  2017-01-09       Impact factor: 4.009

10.  Cerebrospinal Fluid Cultures in Traumatic Brain Injury: Is It Worth It? A Two-Center Study.

Authors:  Navpreet K Dhillon; Saad Sahi; Galinos Barmparas; Nikhil T Linaval; Ting Lung Lin; Shouri Lahiri; Carlos V R Brown; Eric J Ley
Journal:  Surg Infect (Larchmt)       Date:  2021-05-05       Impact factor: 2.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.